TrialThe lancet. Diabetes & endocrinology2019

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.

Alexander Dimitri Miras et al.PubMed ↗Publisher ↗

No numbers read from the abstract.